NeoRx
Executive Summary
PLA submitted for Onco Trac Small Cell Lung Cancer imaging product on Dec. 26 for use as a primary imaging procedure in "staging" this type of small cell cancer. Invitron, which is the contract bulk antibody producer for the NeoRx product, said it is "on track" for filing its PLA for the product "within 60 days".